Our Procedures

With 30 years of experience in ablation, we are pioneers in minimally invasive oncology procedures

Image guided cancer ablation

Image-guided cancer ablation involves the placement of needles into a tumor...

Intratumoral immunotherapy inyection

Immunotherapy has proven effective in fighting many cancers, including melanoma and...

Immunotherapy Combined with Image-Guided Cancer Ablation

A much stronger anti-cancer immune response than either therapy alone....

Breast Cancer Cryoablation

We offer the next advancement in breast cancer treatment...

Lung Cancer Ablation

Tumor ablation is a procedure that uses heat or cold treatment. It is a safe and effective minimally invasive procedure...

Kidney Cancer Ablation

Kidney cryoablation is an alternative to surgery for the treatment of kidney tumors....

Frequently asked questions

Key Findings on Cryoablation

What is cryoablation?

Cryoablation is a minimally invasive technique that uses cycles of freezing and thawing to destroy breast cancer cells. It can treat benign breast lesions, small early-stage breast cancers, or specific metastatic sites in patients who are not eligible for surgery.

What are the advantages of cryoablation?

Faster recovery and excellent cosmetic results.
High patient satisfaction and lower costs compared to surgery.
It is an outpatient procedure performed under local anesthesia.

Is cryoablation FDA approved?

While cryoablation shows promise, it is not yet FDA-approved as a standard treatment for breast cancer. It is currently used in clinical trials or for patients who are not candidates for surgery.

Are there any clinical trial results?

The ACOSOG Z1072 trial showed that cryoablation completely destroyed tumors in 92% of cases for tumors ≤2 cm and 100% for tumors <1 cm.
The ICE3 trial reported a low 2.06% recurrence rate of breast tumors on the same side at an average follow-up of 34.83 months, with high satisfaction from both patients and physicians.
A 5-year follow-up study by Dr. Richard Fine showed a 4.3% recurrence rate of breast tumors on the same side, 96.7% breast cancer survival, and 88.6% overall survival in older women.

What will happen to my immune response?

Cryoablation may boost the body’s immune response against tumors by releasing tumor antigens. Combining cryoablation with immunotherapy is a promising area of research.

Cryoablation is an emerging, minimally invasive alternative to surgery for certain early-stage breast cancer patients. It offers several benefits and has shown promising results in early clinical trials. However, its long-term effectiveness compared to standard treatments is still being studied. Researchers are also exploring combining cryoablation with immunotherapy to potentially improve outcomes.